uBriGene Biosciences Inc is the same entity as uBriGene (duplicate entry, different ID). This is the China-headquartered entity of the same global CRDMO providing one-stop viral vector-based CDMO services for research and clinical applications. Series C+ funding of 150M CNY (~$20M USD). Same website, same capabilities. See uBriGene entry (ID 10a6a05c) for full details.
Cell and gene therapy CDMO, viral vector manufacturing (AAV, lentivirus), mRNA-LNP manufacturing, CAR-T cell therapy, plasmid GMP manufacturing
5 sites worldwide
No reviews available yet.
No documents available.